Guwahati, 20th February 2026: Neurological disorders rank among the top causes of disability globally, and their impact has grown markedly over the last several decades. In India, they contribute to around 10% of the overall burden of disease.

Gurugram-based Medanta –The Medicity, one of the largest private multi-specialty tertiary and quaternary care providers operating in the North and East regions of India, is an internationally recognised destination for Deep Brain Stimulation (DBS), widely known as ‘Brain Pacemaker’ surgery. The programme has emerged as a centre of excellence, offering advanced treatment options and renewed hope to patients suffering from disabling neurological conditions. This neurostimulation procedure, offered by Dr. Anirban Deep Banerjee, Director, Neurosurgery, Institute of Neurosciences at Medanta Gurugram, is recognised for providing meaningful relief to advanced-stage Parkinson’s disease, dystonia, refractory epilepsy (adult onset), essential tremor, and advanced obsessive-compulsive disorder (OCD).

This comprehensive treatment combines cutting-edge technology with personalised care. Medanta employs advanced imaging techniques for precise brain targeting and utilizes state-of-the-art innovations, such as directional leads for multi-dimensional neuromodulation and real-time brain-sensing biomarker feedback for symptom-responsive stimulation.

Dr. Anirban Deep Banerjee, Director, Neurosurgery, Institute of Neurosciences at Medanta Gurugram said, “DBS or Brain Pacemaker Surgery is a transformative therapy wherein electrodes are implanted in specific affected areas of the brain to regulate abnormal signals, restoring motor function, and greatly enhancing quality of life. At Medanta, our focus is on making advanced treatments like DBS more accessible, helping patients reclaim their quality of life when medicines and standard therapies fail to control symptoms.”

Dr. Banerjee has performed more than 300 Deep Brain Stimulation (DBS) procedures over the past decade-and-a-half, achieving consistently high success rates. His extensive experience and outcomes have firmly established him as one of the most trusted and sought-after neurosurgeons for DBS surgery in India.

At Medanta, the DBS programme goes beyond conventional surgical expertise. It incorporates patient- and condition-specific advanced technologies, including AI-guided precision targeting of brain regions and remote programming capabilities. These innovations allow for highly personalised treatment and fine-tuning of therapy even after the procedure.